For the past 36 years, I've shown people from all walks of life how to make money in the markets. Retired stockbrokers... presidents of companies... people with almost no financial experience... and everything in between.
But I haven't done it the usual way…
My method is different. It's unlike anything you’ve probably ever seen before.
The richest men on the planet are in on this new tech - and they're betting big on it:
Jeff Bezos, Elon Musk, even Bill Gates!
And tech expert Lou Basenese has discovered a secret "backdoor" to help YOU potentially make up to 10x your money from this trend by investing in a private Silicon Valley startup...
Stockguru LLC 711 SW 24th Ave Boynton, Beach, FL 33435
This email is being sent from Investing Chatter. If you no longer wish to receive Investing Chatter emails, please click to unsubscribe.
DISCLAIMER: Stocks and options trading have large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stocks and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell stocks or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed in this report. The past performance of any trading system or methodology is not necessarily indicative of future results. All trades, patterns, charts, systems, etc., discussed in this report are for illustrative purposes only and not to be construed as specific advisory recommendations. Information contained in this correspondence is intended for informational purposes only and was obtained from sources believed to be reliable. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted.
The richest men on the planet are in on this new tech - and they're betting big on it:
Jeff Bezos, Elon Musk, even Bill Gates!
And tech expert Lou Basenese has discovered a secret "backdoor" to help YOU potentially make up to 10x your money from this trend by investing in a private Silicon Valley startup... [ad]
This year started off with a bang for DKNG stockholders. The share price ran fast and hard, from $45 to $75 in just a couple of months.
However, that $75 level turned out to be a fierce resistance point, as the bulls were rejected there several times in March.
DISCLAIMER: Stocks and options trading have large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stocks and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell stocks or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed in this report. The past performance of any trading system or methodology is not necessarily indicative of future results. All trades, patterns, charts, systems, etc., discussed in this report are for illustrative purposes only and not to be construed as specific advisory recommendations. Information contained in this correspondence is intended for informational purposes only and was obtained from sources believed to be reliable. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted.
UpTrendAlerts, 711 SW 24th Ave, Boynton Beach, FL 33435, United States
It's back-to-school season and this year is expected to be especially strong for U.S. retailers. According to the latest forecast from credit card company Mastercard, back-to-school sales throughout America are expected to grow 6.7% from 2019 levels and 5.5% from last year during the Covid-19 pandemic's zenith. With vaccinated parents and students looking for a fresh start and to put the global pandemic behind them, spending on back to school items is expected to be robust.
Ocugen still hopes its Covid-19 vaccine gets approved to start making revenue. OCGN-stock could be worth as much as $9.09 or 19% over today's price assuming its Covid-19 vaccine gets approval.
Bankruptcy Judge Is Set To Rule On Purdue Pharma's Opioid Settlement Plan
